Gene Replacement Therapy Clinical Trial for Participants With Spinal Muscular Atrophy Type 1

Clinical trial NCT03306277 · COMPLETED

Trial details

NCT number: NCT03306277
Sponsor: Novartis Gene Therapies
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

SMA - Spinal Muscular Atrophy Gene Therapy

Start date: 2017-10-24
Primary completion: 2019-11-12
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.